Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Coll Physicians Surg Pak ; 34(3): 351-354, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38462874

RESUMO

OBJECTIVE: To assess the impact of vitamin B12 levels in the failure of the dapoxetine used in premature ejaculation (PE) treatment. STUDY DESIGN: Experimental study. Place and Duration of the Study: Andrology Clinic, between May and December 2020. METHODOLOGY: Patients with premature ejaculation complaints completed the Premature Ejaculation Diagnostic Tool (PEDT) questionnaire. Patients were also asked to fill in the Premature Ejaculation Profile (PEP) surveys. Intravaginal ejaculation latency time (IELT) were recorded based on the estimates of patients. Serum vitamin B12 levels were evaluated based on blood samples. All patients were advised to use dapoxetine 30 mg, 1-3 hours prior to intercourse. After four weeks, patients were asked to complete the PEP questionnaire again. IELT times were recorded. RESULTS: A total of 62 patients were included in the study. A total of 39 patients (62.90%) were satisfied with the treatment of the dapoxetine. In comparison to patients who benefited from dapoxetine treatment and those who did not, vitamin B12 levels of patients who did not benefit from dapoxetine were found to be significantly lower (p=0.005). CONCLUSION: Vitamin B12 deficiency can reduce the effectiveness of dapoxetine treatment in patients with PE. It is important to evaluate serum vitamin B12 levels for the evaluation of patients with PE. KEY WORDS: Premature ejaculation, Dapoxetine, Vitamin B12, Serotonin, Treatment.


Assuntos
Benzilaminas , Naftalenos , Ejaculação Precoce , Masculino , Humanos , Ejaculação Precoce/tratamento farmacológico , Resultado do Tratamento , Ejaculação , Vitamina B 12/uso terapêutico
2.
Urologia ; 89(4): 517-520, 2022 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-35471101

RESUMO

PURPOSE: Bladder diary and questionnaire forms have an important role in the diagnosis of overactive bladder (OAB) syndrome and can predict response to OAB treatment. We aimed to evaluate the correlation between three different validated Turkish OAB questionnaires and bladder diary form. METHODS: Patients aged over 18 years who admitted to the urology outpatient clinic with OAB symptoms between March 2019 and April 2020 were enrolled into the study. Demographic data of the patients were recorded, and they were asked to complete a 3-days bladder diary. In addition, the patients filled Turkish validated OAB version-8 (OABv8), the International Consultation of Incontinence Questionnaire-Short Form (ICIQ-SF), and OAB Symptom Score (OABSS) questionnaire. The relationship between these questionnaire forms and bladder diary was evaluated with statistical analysis. The significant p was p < 0.05. RESULTS: A total of 592 patients were included in the study. The mean total points of the questionnaire forms were 22.07 ± 8.34 (0-38) for OABv8, 10.78 ± 7.21 (0-21) for ICIQ-SF, and 9.36 ± 3.53 (0-15) for OABSS, respectively. There was a positive poor correlation between OABv8 questionnaire form and nocturia (r = 0.287, p = 0.013). There was a positive moderate correlation between OABSS and the number of micturition (r = 0.405, p = 0.03) and nocturia (r = 0.508, p = 0.036), and the urgency incontinence was negatively moderate correlations (r = -0.525, p = 0.041). CONCLUSION: Both questionnaire forms and bladder diaries are important in the evaluation of OAB patients. According to our results the bladder diary and OABSS questionnaire forms were interrelated.


Assuntos
Noctúria , Bexiga Urinária Hiperativa , Incontinência Urinária , Adulto , Humanos , Pessoa de Meia-Idade , Noctúria/diagnóstico , Inquéritos e Questionários , Bexiga Urinária , Bexiga Urinária Hiperativa/diagnóstico , Incontinência Urinária/diagnóstico
3.
Int J Impot Res ; 34(6): 610-613, 2022 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-34341519

RESUMO

This study aims to assess the validity and reliability of the Turkish version of the FSFI-6 questionnaire,an abbreviated version of FSFI-19,a common tool for evaluating female sexual function. The study included 120 female patients aged between 18-65 years who presented to the urology clinic between December 2019 and March 2020. The Turkish version of FSFI-6 was translated from the English version for validation. The abridged FSFI-6 questionnaire consists of questions 2, 4, 7, 11, 16, and 17 of the FSFI-19 form. We recorded the demographic data of the patients. All subjects filled out the FSFI-19 and FSFI-6 questionnaires. The patients were asked to fill out the questionnaires again after two weeks. The mean age of the subjects was 46.58 ± 9.89 years (28-63). The results of the reliability analysis indicated that the intraclass correlation coefficient of the total FSFI-6 score was 0.92 (weighted kappa coefficients of individual items, 0.868-0.975) and the Cronbach's alpha was 0.862. The validity analysis indicated that the mean total FSFI-6 score was strongly correlated with the mean FSFI-19 score (p < 0.001, r = 0.997). In the test-retest analysis,the kappa coefficient was calculated as 0.891. The FSFI-19 and FSFI-6 scores of the patients with (n = 52) and without climacturia (n = 68) were compared, and it was observed that the scores of the patients with climacturia were significantly lower than those without climacturia (p < 0.001). The abbreviated FSFI-6 questionnaire is a valuable tool for screening women with FSD. It can be used more extensively due to being short and easy to apply. Our results approve the Turkish version of the questionnaire as a valid and reliable tool for evaluating FSD.


Assuntos
Disfunções Sexuais Psicogênicas , Adolescente , Adulto , Idoso , Feminino , Humanos , Programas de Rastreamento , Pessoa de Meia-Idade , Psicometria , Reprodutibilidade dos Testes , Disfunções Sexuais Psicogênicas/diagnóstico , Inquéritos e Questionários , Adulto Jovem
4.
Urologia ; 83(1): 31-5, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26350042

RESUMO

OBJECTIVE: The objective of this study is to identify the variables that affect young urologists' productivity and academic career choice. PATIENTS AND METHODS: We have conducted an internet-based national survey for urologists randomly sampled from the database of Turkish Urological Association and 110 physicians completed this survey. Participants were asked to answer three-page questionnaire including 37 questions, which takes around 5 min to complete. Questionnaire was consisting of four main sections: 'demography', 'education', 'working conditions' and 'quality of life'. RESULTS: Increased dedicated research time, being interested in an academic career, being Fellow of the European Board of Urology (FEBU), having English proficiency, and greater numbers of manuscript publication during residency were associated with increased productivity after residency (p = 0.001, p = 0.028, p = 0.046, p<0.001 and p<0.001, respectively). The remaining variables including age at marriage, age at having a child, monthly salary, length of residency, having a mentor or role model during residency showed no significant relationship with manuscript publications. Twenty-nine physicians (26.4%) stated that they had once been interested in their residency but were no longer interested in academic urology. Reasons for this loss of academic interest included lack of effective mentor or role model (27.2%), bureaucracy (17%), financial issues (13.6%), mandatory rule to work in public hospitals (18.2%) or military hospitals (9%) and language problems (21.6%). CONCLUSIONS: Our data indicate that increased time spent for research, being interested in an academic career, being an FEBU, having English proficiency, and greater publication during residency were associated with increased numbers of publications and academic career choice.


Assuntos
Escolha da Profissão , Editoração/estatística & dados numéricos , Urologia , Adulto , Idoso , Eficiência , Humanos , Masculino , Pessoa de Meia-Idade , Autorrelato
5.
Andrologia ; 48(5): 605-606, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26370066

RESUMO

Various types of drugs are being used to treat patients with chronic hepatitis B infection. However, these treatment modalities are not without side effects, which may result in decreased patient adherence. Entecavir is an oral reverse transcriptase inhibitor, which is widely used in patients with hepatitis B. Although headache, fatigue and nausea are well-documented side effects of entecavir, its sexual side effects have not been reported yet. We here report on two male patients with chronic hepatitis B infection who reported decreased libido under entecavir treatment.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...